{"public_id":"cl_43c2667a902d1d590e04e139d80661e6","status":"active","superseded_by_public_id":null,"corpus_id":97106121,"text":"Galactomannans are used not only as inert excipients but also to modify drug release, especially in colonic environments, as matrix or coating materials.","confidence":0.96,"paper":{"corpus_id":97106121,"title":"Pharmaceutical use of galactomannans","url":"https://sah.borca.ai/papers/97106121"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_3bd3d4bf89ff5a507c813972c730a52f","name":"matrix or coating material","description":"A formulation component used to form the bulk matrix of a dosage form or to coat its surface.","types":["excipient","formulation component"],"url":"https://sah.borca.ai/concepts/co_3bd3d4bf89ff5a507c813972c730a52f"},{"public_id":"co_3dcffb502831db94c72733560af5f7cd","name":"galactomannans","description":"Plant-derived polysaccharides composed of a mannose backbone with galactose side chains, used in pharmaceutical formulations.","types":["polysaccharide","excipient"],"url":"https://sah.borca.ai/concepts/co_3dcffb502831db94c72733560af5f7cd"},{"public_id":"co_a7829c351f390965f1bfdb23d4bb90af","name":"drug release modification","description":"Adjustment of the rate or site at which a drug is released from a formulation.","types":["drug delivery mechanism"],"url":"https://sah.borca.ai/concepts/co_a7829c351f390965f1bfdb23d4bb90af"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_43c2667a902d1d590e04e139d80661e6"}